Home » Stocks » XYNO

Xynomic Pharmaceutical Holdings Inc. (XYNO)

Jun 17, 2021 - XYNO was delisted (reason: merged with Xu-Nuo Pharma)
Stock Price: $2.22 USD 0.00 (0.00%)
Updated Jun 16, 2021 9:30 AM EDT
Market Cap 102.73M
Revenue (ttm) n/a
Net Income (ttm) -26.80M
Shares Out 46.27M
EPS (ttm) -4.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Jul 29, 2021
Last Price $2.22
Previous Close $2.22
Change ($) 0.00
Change (%) 0.00%
Day's Open 2.22
Day's Range 2.22 - 2.22
Day's Volume 0
52-Week Range 0.20 - 3.79

News

There are no news available yet.

About XYNO

Xynomic Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule drug candidates for the treatment of cancer in the People's Republic of China and the United states. Its lead drug candidate is Abexinostat, an orally dosed hydroxamic acid-based small molecule histone deacetylase inhibitor. The company develops pazopanib a molecular therapy for treating renal cell carcinoma; XYN-603 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory (R/R) mantle cell lymphoma ... [Read more...]

Industry
Biotechnology
Founded
2016
Stock Exchange
OTCMKTS
Ticker Symbol
XYNO
Full Company Profile

Financial Performance

Financial Statements